Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
50,084,803
-
Share change
-
-1,034,054
-
Total reported value
-
$2,655,680,021
-
Put/Call ratio
-
24%
-
Price per share
-
$53.04
-
Number of holders
-
240
-
Value change
-
-$87,203,336
-
Number of buys
-
125
-
Number of sells
-
116
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q4 2021
As of 31 Dec 2021,
HAEMONETICS CORP - Common Stock (HAE) was held by
240 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,084,803 shares.
The largest 10 holders included
BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Neuberger Berman Group LLC, Capital Research Global Investors, STATE STREET CORP, FRANKLIN RESOURCES INC, WESTFIELD CAPITAL MANAGEMENT CO LP, LGT CAPITAL PARTNERS LTD., and Fisher Asset Management, LLC.
This page lists
240
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.